Showing results (1-10 of 440) with videos related to
Sort By:
Pageof 44
Canadian Medical Association Journal|February 3, 1979
Cancer immunotherapyS P Richman, J U Gutterman, E M HershJAMA|December 22, 1975
Epilesional scarification. Preliminary report of a new approach to local immunotherapy with BCGS P Richman, G M Mavligit, R Wolk, et al.Cancer Treatment Reports|May 1, 1976
Chemotherapy versus chemoimmunotherapy of head and neck cancer: report of a randomized studyS P Richman, R B Livingston, J U Gutterman, et al.Cancer|November 1, 1978
Immunotherapy with BCG administered by scarification: standardization of reactions and management of side effectsG N Hortobagyi, S P Richman, K Dandridge, et al.Cancer Treatment Reports|May 1, 1981
Administration of BCG cell wall skeleton into malignant effusions: toxic and therapeutic effectsS P Richman, E M Hersh, J U Gutterman, et al.The Medical Clinics of North America|September 1, 1976
Immunotherapy of leukemiaE M Hersh, J U Gutterman, G M MavligitJournal of Interferon Research|January 1, 1982
Clinical and immunological study of beta interferon by intramuscular route in patients with metastatic breast cancerJ R Quesada, J U Gutterman, E M HershJournal of the National Cancer Institute|October 1, 1976
Effect of BCG (Tice strain) on primary sensitization to 2,4-dinitrochlorobenzene and on established delayed hypersensitivity in human malignant melanomaG M Mavligit, J U Gutterman, E M HershCancer|April 15, 1986
Treatment of hairy cell leukemia with alpha interferonsJ R Quesada, J U Gutterman, E M HershCancer|June 1, 1982
Actinomycin-D plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamine (DTIC) with or without intravenous Corynebacterium parvum in metastatic malignant melanomaA Robidoux, J U Gutterman, G P Bodey, et al.Pageof 44